In syngeneic tumor models, CD34+ humanized mice, and intestine-specific Alkbh5 transgenic mice, ALKBH5 promoted MDSC accumulation while diminishing NK and CD8+ T-cell infiltration, thereby driving tumorigenesis. Here, ALKBH5 is linked to neoplasm.